Several studies have reported similar performance of plasma NFL in differentiating AD from normal controls (Gaiottino et al., 2013, Pereira et al., 2017, Lin et al., 2018, Benedet et al., 2019, Mattsson et al., 2019). The gene discussed is NEFL; the disease is Alzheimer disease.